Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Space | 3 | 2010 | 90 | 0.700 |
Why?
|
| Cell Physiological Phenomena | 2 | 2010 | 27 | 0.560 |
Why?
|
| Mitochondria | 5 | 2025 | 623 | 0.540 |
Why?
|
| Insulin-Secreting Cells | 4 | 2011 | 442 | 0.540 |
Why?
|
| Calcium | 4 | 2010 | 1205 | 0.510 |
Why?
|
| Insulin | 3 | 2011 | 1190 | 0.450 |
Why?
|
| Microelectrodes | 3 | 2010 | 98 | 0.440 |
Why?
|
| Biofouling | 1 | 2014 | 2 | 0.420 |
Why?
|
| Biofilms | 1 | 2014 | 50 | 0.410 |
Why?
|
| Seawater | 1 | 2014 | 50 | 0.410 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 2 | 2025 | 7 | 0.390 |
Why?
|
| Protein Deglycase DJ-1 | 2 | 2025 | 6 | 0.390 |
Why?
|
| Dopaminergic Neurons | 2 | 2025 | 30 | 0.380 |
Why?
|
| Glycosyltransferases | 2 | 2020 | 24 | 0.330 |
Why?
|
| Chlorides | 2 | 2008 | 108 | 0.320 |
Why?
|
| Electrochemical Techniques | 1 | 2010 | 7 | 0.320 |
Why?
|
| Ion-Selective Electrodes | 1 | 2010 | 5 | 0.320 |
Why?
|
| Potassium | 2 | 2009 | 271 | 0.320 |
Why?
|
| Malates | 1 | 2009 | 6 | 0.300 |
Why?
|
| Malate Dehydrogenase | 1 | 2009 | 9 | 0.300 |
Why?
|
| Pyruvate Carboxylase | 1 | 2009 | 7 | 0.300 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2009 | 20 | 0.300 |
Why?
|
| Sodium | 1 | 2008 | 340 | 0.250 |
Why?
|
| Ion Channel Gating | 1 | 2009 | 338 | 0.250 |
Why?
|
| Biological Clocks | 1 | 2007 | 81 | 0.240 |
Why?
|
| Database Management Systems | 1 | 2006 | 44 | 0.240 |
Why?
|
| Glucose | 4 | 2011 | 701 | 0.230 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 128 | 0.230 |
Why?
|
| Mesencephalon | 1 | 2025 | 68 | 0.230 |
Why?
|
| User-Computer Interface | 1 | 2006 | 194 | 0.220 |
Why?
|
| Pharmaceutical Preparations | 1 | 2006 | 98 | 0.220 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 198 | 0.220 |
Why?
|
| Organizers, Embryonic | 1 | 2023 | 6 | 0.210 |
Why?
|
| Parkinson Disease | 1 | 2025 | 178 | 0.200 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2023 | 172 | 0.180 |
Why?
|
| Sports for Persons with Disabilities | 1 | 2021 | 1 | 0.180 |
Why?
|
| Youth Sports | 1 | 2021 | 8 | 0.180 |
Why?
|
| Databases, Factual | 1 | 2006 | 1010 | 0.180 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 472 | 0.170 |
Why?
|
| Biochemistry | 1 | 2020 | 31 | 0.160 |
Why?
|
| Polysaccharides | 1 | 2020 | 96 | 0.160 |
Why?
|
| Adenosine Triphosphate | 4 | 2023 | 329 | 0.150 |
Why?
|
| Plants | 1 | 2020 | 127 | 0.150 |
Why?
|
| Exercise | 1 | 2021 | 354 | 0.140 |
Why?
|
| Succinates | 2 | 2009 | 25 | 0.140 |
Why?
|
| Antitrichomonal Agents | 1 | 2016 | 1 | 0.130 |
Why?
|
| Ferrous Compounds | 1 | 2016 | 18 | 0.130 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 79 | 0.130 |
Why?
|
| Arabidopsis | 1 | 2020 | 331 | 0.130 |
Why?
|
| Antimalarials | 1 | 2016 | 21 | 0.130 |
Why?
|
| Animals | 12 | 2023 | 28945 | 0.120 |
Why?
|
| Quinolines | 1 | 2016 | 89 | 0.120 |
Why?
|
| Mice | 7 | 2019 | 12562 | 0.110 |
Why?
|
| Proton-Translocating ATPases | 1 | 2014 | 24 | 0.110 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2014 | 11 | 0.110 |
Why?
|
| Benzothiazoles | 1 | 2014 | 17 | 0.110 |
Why?
|
| Membrane Potentials | 2 | 2007 | 442 | 0.110 |
Why?
|
| Cricetulus | 2 | 2016 | 132 | 0.110 |
Why?
|
| CHO Cells | 2 | 2016 | 196 | 0.100 |
Why?
|
| Biomass | 1 | 2014 | 43 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2017 | 984 | 0.100 |
Why?
|
| Cyclosporine | 1 | 2014 | 242 | 0.100 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2014 | 43 | 0.100 |
Why?
|
| Home Care Services | 1 | 2015 | 77 | 0.100 |
Why?
|
| Phospholipids | 1 | 2014 | 113 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 238 | 0.100 |
Why?
|
| Phosphates | 1 | 2014 | 167 | 0.100 |
Why?
|
| Hydrogen Peroxide | 2 | 2011 | 165 | 0.100 |
Why?
|
| Meningococcal Infections | 1 | 2012 | 1 | 0.100 |
Why?
|
| Purpura Fulminans | 1 | 2012 | 2 | 0.100 |
Why?
|
| Vitamin K 3 | 1 | 2011 | 1 | 0.090 |
Why?
|
| Mice, Inbred Strains | 2 | 2009 | 297 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2015 | 387 | 0.090 |
Why?
|
| Bacteremia | 1 | 2012 | 108 | 0.090 |
Why?
|
| Cytosol | 2 | 2009 | 198 | 0.090 |
Why?
|
| Shock, Septic | 1 | 2012 | 125 | 0.090 |
Why?
|
| Oxygen Consumption | 2 | 2009 | 257 | 0.080 |
Why?
|
| Buffers | 1 | 2010 | 26 | 0.080 |
Why?
|
| Cell Wall | 2 | 2020 | 75 | 0.080 |
Why?
|
| Adenosine Diphosphate | 1 | 2009 | 63 | 0.070 |
Why?
|
| Diffusion | 1 | 2009 | 95 | 0.070 |
Why?
|
| Citric Acid | 1 | 2009 | 48 | 0.070 |
Why?
|
| Rats | 3 | 2011 | 4154 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1351 | 0.070 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 191 | 0.070 |
Why?
|
| Cricetinae | 1 | 2009 | 544 | 0.070 |
Why?
|
| Artifacts | 1 | 2010 | 251 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1534 | 0.070 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2008 | 38 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 402 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 223 | 0.070 |
Why?
|
| Ions | 1 | 2008 | 80 | 0.070 |
Why?
|
| Mitochondrial Membranes | 2 | 2019 | 20 | 0.070 |
Why?
|
| NADP | 1 | 2007 | 49 | 0.070 |
Why?
|
| Glucose-6-Phosphate | 1 | 2007 | 3 | 0.070 |
Why?
|
| Keto Acids | 1 | 2007 | 5 | 0.070 |
Why?
|
| Pyruvates | 1 | 2007 | 13 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 828 | 0.070 |
Why?
|
| Palmitates | 1 | 2007 | 17 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2010 | 2943 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 2794 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 286 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2009 | 696 | 0.060 |
Why?
|
| Chlamydomonas | 1 | 2005 | 20 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2025 | 30 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2005 | 35 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 1010 | 0.060 |
Why?
|
| Lilium | 1 | 2004 | 1 | 0.060 |
Why?
|
| Ventral Tegmental Area | 1 | 2025 | 46 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2009 | 1158 | 0.050 |
Why?
|
| Pollen | 1 | 2004 | 87 | 0.050 |
Why?
|
| Male | 6 | 2025 | 45884 | 0.050 |
Why?
|
| Humans | 10 | 2025 | 96175 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2023 | 143 | 0.050 |
Why?
|
| Models, Biological | 1 | 2010 | 1815 | 0.050 |
Why?
|
| Time Factors | 2 | 2010 | 5585 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2005 | 313 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2002 | 151 | 0.050 |
Why?
|
| Apoptosis | 2 | 2014 | 1763 | 0.050 |
Why?
|
| Recreation | 1 | 2021 | 9 | 0.050 |
Why?
|
| Cell Size | 1 | 2002 | 71 | 0.050 |
Why?
|
| Perciformes | 1 | 2002 | 38 | 0.050 |
Why?
|
| Zygote | 1 | 2002 | 43 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1267 | 0.040 |
Why?
|
| Pediatricians | 1 | 2021 | 24 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2021 | 52 | 0.040 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 33 | 0.040 |
Why?
|
| Xylans | 1 | 2020 | 1 | 0.040 |
Why?
|
| Glucans | 1 | 2020 | 10 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 137 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2020 | 118 | 0.040 |
Why?
|
| Physician's Role | 1 | 2021 | 186 | 0.040 |
Why?
|
| Potassium Channels | 1 | 2002 | 359 | 0.040 |
Why?
|
| Homeostasis | 1 | 2002 | 467 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 32 | 0.040 |
Why?
|
| Patient Participation | 1 | 2021 | 244 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2021 | 308 | 0.040 |
Why?
|
| Hypoxia | 1 | 2023 | 683 | 0.040 |
Why?
|
| Child | 2 | 2021 | 7629 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 706 | 0.030 |
Why?
|
| United States | 3 | 2017 | 7774 | 0.030 |
Why?
|
| Reimbursement Mechanisms | 1 | 2017 | 41 | 0.030 |
Why?
|
| Trichomonas vaginalis | 1 | 2016 | 3 | 0.030 |
Why?
|
| Plasmodium falciparum | 1 | 2016 | 55 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 133 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 180 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1561 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1322 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2002 | 1030 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 1032 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2014 | 39 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 2163 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2005 | 509 | 0.030 |
Why?
|
| Omentum | 1 | 2014 | 75 | 0.030 |
Why?
|
| Telemedicine | 1 | 2017 | 230 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 392 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 191 | 0.020 |
Why?
|
| Netherlands | 1 | 2012 | 25 | 0.020 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2011 | 10 | 0.020 |
Why?
|
| Insulinoma | 1 | 2011 | 39 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 3490 | 0.020 |
Why?
|
| Female | 4 | 2025 | 50079 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2012 | 304 | 0.020 |
Why?
|
| NAD | 1 | 2011 | 99 | 0.020 |
Why?
|
| Hospitalization | 1 | 2017 | 948 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 411 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 1103 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 517 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 9899 | 0.020 |
Why?
|
| Quality of Life | 1 | 2017 | 1818 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2011 | 559 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2092 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1761 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1973 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 3976 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 20970 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2581 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 201 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 725 | 0.010 |
Why?
|
| Spain | 1 | 2005 | 35 | 0.010 |
Why?
|
| Fresh Water | 1 | 2005 | 24 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2005 | 105 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 28374 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 3364 | 0.010 |
Why?
|
| Fluorescence | 1 | 2005 | 106 | 0.010 |
Why?
|
| Anion Exchange Resins | 1 | 2004 | 2 | 0.010 |
Why?
|
| Chloride Channels | 1 | 2004 | 43 | 0.010 |
Why?
|
| Culture Media | 1 | 2004 | 150 | 0.010 |
Why?
|
| Brain | 1 | 2014 | 2481 | 0.010 |
Why?
|
| Quinine | 1 | 2002 | 7 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2002 | 15 | 0.010 |
Why?
|
| Mercuric Chloride | 1 | 2002 | 11 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 17 | 0.010 |
Why?
|
| Population Density | 1 | 2002 | 70 | 0.010 |
Why?
|
| Muscle Relaxants, Central | 1 | 2002 | 11 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 133 | 0.010 |
Why?
|
| Potassium Channel Blockers | 1 | 2002 | 67 | 0.010 |
Why?
|
| Oxidants | 1 | 2002 | 86 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 406 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 707 | 0.010 |
Why?
|